Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivermectin for Prevention of COVID-19 Hospitalization
NCT05993143Phase 3Terminated
- Sponsor
- Insud Pharma
- Start
- Jan 2021
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ivermectin in coronavirus disease 2019 (COVID-19), sponsored by Insud Pharma. Started Jan 2021; status: terminated.
02
Drugs
ivermectin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05993143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05993143.